NCT01539525

Brief Summary

The investigators propose to use obstetric-gynecological clinics to conduct a randomized clinical trial that would compare two SBIRTS (Screening, Brief Intervention, Referral and Treatment), delivered either by a trained nurse or by computer, to usual care (a control condition). As part of this trial, the investigators will include outcomes that allow us to assess the cost effectiveness of these three conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
439

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

September 5, 2011

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 27, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2015

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

April 14, 2017

Completed
Last Updated

April 14, 2017

Status Verified

March 1, 2017

Enrollment Period

3.4 years

First QC Date

August 3, 2011

Results QC Date

September 29, 2016

Last Update Submit

March 2, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Days Per Month of Primary Substance Use

    Participants completed a timeline followback at each assessment, reporting days of primary substance use. Outcomes reported are raw means and standard deviations.

    7 non-overlapping monthly intervals from baseline to month 6

  • Treatment Utilization

    Treatment utilization assessed via participant self-report at each follow-up interview, and with the exception of self-help groups, verified with providers. We also reviewed the medical record for use of medication indicative of treatment (e.g., nicotine replacement therapy).

    baseline to 6 months

Secondary Outcomes (2)

  • Rates of STDs

    baseline to 6 months

  • Mean Cost for Each Intervention

    6 months

Study Arms (3)

Motivational Interview

EXPERIMENTAL

Motivational interview provided by a clinical research nurse or physician.

Behavioral: Motivational Interview

Motivational Interview-Electronic

ACTIVE COMPARATOR

Motivational Interview provided by an interactive computer program.

Behavioral: Motivational Interview

Treatment as Usual

PLACEBO COMPARATOR

No intervention- resource list provided.

Other: Treatment as Usual

Interventions

Motivational Interview provided by either a Nurse or Computer

Motivational InterviewMotivational Interview-Electronic

Subjects given a brochure listing relevant recovery resources in the local area.

Treatment as Usual

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • In order to participate, women must meet the following criteria:
  • Are non-pregnant and meet ASSIST criteria for at least moderate risk for alcohol (≥11) or drug (≥4) abuse or dependence (tobacco or illicit drugs, including cocaine, opiates, methamphetamine, marijuana or a prescription drug used in a medically inappropriate manner).
  • Are pregnant and meet ASSIST criteria for at least mild to moderate risk for alcohol (≥6) or drug (≥4) abuse or dependence (alcohol, tobacco, an illicit drug, or a prescription drug in a medically inappropriate manner). We define pregnant women who use alcohol or drugs at least monthly in the last 90 days as eligible because alcohol and many of the other substances (eg. tobacco) are teratogens and use in pregnancy would be consistent with a diagnosis of abuse ("recurrent use in situations in which it is physically hazardous"). This level of use in pregnancy also indicates a greater likelihood of problematic substance use.
  • Have used their primary substance at least once within the prior 28 days.
  • Are aged 18 or more. We include participants who are aged 18 or older because parents may not be available at screening to provide consent for non-pregnant participants and subjects may not wish to disclose drug or alcohol abuse to a parent.

You may not qualify if:

  • Women are ineligible if they have any of the following criteria:
  • Are unable to speak English.
  • Are incarcerated or at risk of incarceration. The YNHH Women's Center provides care to incarcerated women. These individuals as well as those at risk of incarceration are excluded because incarceration precludes their ability to seek specialty drug or alcohol abuse treatment (a dependent measure).
  • Have a cognitive disorder that would impair their ability to provide informed consent or provide accurate information.
  • Require immediate hospitalization because of general medical needs or due to active suicidal or homicidal ideation or other behavioral health problems. We exclude individuals who are in need of immediate hospitalization because hospitalization will render it more difficult for them to immediately follow-up on a referral and because providers, rather than subjects, may be making the decision to initiate treatment. Hospitalization would also potentially force women who smoke to initiate treatment for tobacco addiction.
  • Are currently participating or have participated in drug abuse treatment, including self-help interventions (eg. 12 step facilitation, smoking cessation interventions), within the last 3 months prior to screening.
  • Are planning to relocate out of the area in the following 6 months. Women who relocate out of the area would be difficult to see for follow up assessments and it would be difficult to confirm treatment attendance in local treatment centers.
  • Have previously participated in this protocol or
  • Are unwilling to participate or accept randomization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yale-New Haven Hospital- York St Campus

New Haven, Connecticut, 06510, United States

Location

Yale-New Haven Hospital-Chapel St Campus

New Haven, Connecticut, 06519, United States

Location

Related Publications (2)

  • Forray A, Martino S, Gilstad-Hayden K, Kershaw T, Ondersma S, Olmstead T, Yonkers KA. Assessment of an electronic and clinician-delivered brief intervention on cigarette, alcohol and illicit drug use among women in a reproductive healthcare clinic. Addict Behav. 2019 Sep;96:156-163. doi: 10.1016/j.addbeh.2019.05.007. Epub 2019 May 8.

  • Loree AM, Yonkers KA, Ondersma SJ, Gilstad-Hayden K, Martino S. Comparing satisfaction, alliance and intervention components in electronically delivered and in-person brief interventions for substance use among childbearing-aged women. J Subst Abuse Treat. 2019 Apr;99:1-7. doi: 10.1016/j.jsat.2019.01.007. Epub 2019 Jan 9.

MeSH Terms

Conditions

AlcoholismTobacco Use DisorderMarijuana AbuseSubstance-Related Disorders

Interventions

Motivational InterviewingTherapeutics

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Limitations and Caveats

Results may not be generalizable to populations differing from population from which sample was drawn. Outcomes relied upon self-report, although we did try to verify through lab results for substance use and medical records/ provider for treatment.

Results Point of Contact

Title
Kimberly A Yonkers
Organization
Yale University School of Medicine

Study Officials

  • Kimberly A Yonkers, MD

    Yale University

    PRINCIPAL INVESTIGATOR
  • Steve Martino, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants received a behavioral intervention that could not be masked. Outcome data were self report and urine tests rom the participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 3, 2011

First Posted

February 27, 2012

Study Start

September 5, 2011

Primary Completion

January 28, 2015

Study Completion

January 28, 2015

Last Updated

April 14, 2017

Results First Posted

April 14, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

We will require data request with delineation of variables of interest. Only de-identified data will be released after evaluation of the request

Locations